December 4, 2014
11:00 am to 12:00 pm EST

Sponsored by

Webinar Description:

Driver mutations and therapeutic escape variants could provide invaluable treatment options if they could be detected early in circulating cell-free DNA. A multimarker detection method capable of detecting these rare variants enables identification for initiation and proliferation in primary tumors and as a noninvasive method for early detection of metastasis. This seminar will detail MALDI-TOF mass spectrometry using the UltraSEEK method on the MassARRAY System and its ability to detect low level mutations in clinical research specimens.

Learning Objectives:

• Rationale for targeted profiling at high sensitivity for clinical and translational research
• Tumor vs. circulating cell-free DNA studies
• Research-use panels available on the MassARRAY System
• Methods to design patient-specific panels

Speakers:

Divya Neelam, MS

Senior Scientist, Applications and Technology
Agena Biosciences

Cost: No cost!

Schedule conflict? Register and you'll receive a copy of the recording!